|
KMID : 0357920040380060401
|
|
Korean Journal of Pathology
2004 Volume.38 No. 6 p.401 ~ p.407
|
|
|
Effect of Atorvastatin, a HMG-CoA Reductase Inhibitor, in Experimental Colitis in Mice
|
|
Park Hyo-Jin
Oh Kwon-Ik
Shin Hyung-Sik
Seo Jae-Nam
Park Young-Euy
Kim Tae-Woon
Choi Eun-Young
|
|
|
Abstract
|
|
|
Background: The statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, are approved for cholesterol reduction, and may also be beneficial in the treatment of inflammatory disease. In this study, atorvastatin was tested in experimental colitis, a disease model of inflammatory bowel disease.
Methods: To induce colitis, dextran sodium sulfate (DSS) or trinitrobenzene sulfonic acid (TNBS) were administrated to C57BL/6 or BALB/c mice. Mice were monitored daily for loss of body weight and survival for indicated days. Colon length and histology were examined after sacrifice.
Results: The administration of DSS induced marked colonic inflammation and shortening, and resulted in a loss of body weight. DSS-induced colitis was not affected by atorvastatin treatment, but in contrast, the administration of atorvastatin relieved TNBS-induced colitis with a resultant rapid recovery of weight loss and a reduction in colonic length shortening. Histologically, inflammatory cell infiltration in the colonic wall, mucosal ulceration and crypt disruption were also suppressed in atorvastatin treated mice.
Conclusions: These results suggest that atorvastatin preserves intestinal integrity in colitis, probably via the modulation of Th cell-mediated immune response, in a manner independent of innate immunity.
|
|
|
KEYWORD
|
|
|
Atorvastatin, inflammatiory bowel disease, Experimental colitis, Th cell mediated immunity, Immunity, Natural
|
|
|
FullTexts / Linksout information
|
|
 
|
|
|
Listed journal information
|
|
  
|
|